Enjaymo Injection, Solution, Concentrate
Product Images NDC 55292-820

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Enjaymo (NDC 55292-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Recordati Rare Diseases, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (1,100 mg/22 mL Vial Carton)

Enjaymo (sutimimab-jome) is an injection with a dosage of 1,100 mg/22 mL (50 mg/mL) for intravenous infusion. It contains polysorbate 80, sodium chloride, sodium phosphate dibasic heptahydrate, sodium phosphate monobasic monohydrate, and Water for Injection, USP. Store this medication refrigerated at 36°F to 46°F and protect it from light. Each ml has 50 mg of sutimimab-jome. It is preservative-free and comes in single-dose vials. Patients should receive the enclosed Medication Guide and any unused portion should be discarded. Made by Recordati Rare Diseases Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.